About Bio-Techne Corporation
Bio-Techne Corporation (TECH) has been publicly traded since 1989, making it a 37-year-old public company. It operates in the Biotechnology industry within the Healthcare sector. The company is headquartered in Minneapolis, United States and employs approximately 3,100 people. With a market capitalization of $8.0 billion, TECH is a mid-sized company with growth potential.
Key Statistics
- Current Price
- $50.85
- Market Cap
- $7.96B
- 52-Week High
- $72.16
- 52-Week Low
- $46.01
- Sector
- Healthcare
- Industry
- Biotechnology
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -13.42% | $58.73 | $50.85 |
| 2025 | -17.89% | $71.53 | $58.73 |
| 2024 | -6.25% | $76.29 | $71.53 |
| 2023 | -6.49% | $81.59 | $76.29 |
| 2022 | -35.69% | $126.87 | $81.59 |
| 2021 | +63.40% | $77.64 | $126.87 |
| 2020 | +45.40% | $53.40 | $77.64 |
| 2019 | +52.67% | $34.98 | $53.40 |
| 2018 | +12.60% | $31.06 | $34.98 |
| 2017 | +27.40% | $24.38 | $31.06 |
| 2016 | +15.77% | $21.06 | $24.38 |
| 2015 | -1.29% | $21.33 | $21.06 |
| 2014 | -1.05% | $21.56 | $21.33 |
| 2013 | +40.82% | $15.31 | $21.56 |
| 2012 | +1.81% | $15.04 | $15.31 |
| 2011 | +5.54% | $14.25 | $15.04 |
| 2010 | -2.56% | $14.63 | $14.25 |
| 2009 | +8.09% | $13.53 | $14.63 |
| 2008 | -1.95% | $13.80 | $13.53 |
| 2007 | +19.12% | $11.58 | $13.80 |
| 2006 | -1.12% | $11.72 | $11.58 |
| 2005 | +44.16% | $8.13 | $11.72 |
| 2004 | +2.80% | $7.91 | $8.13 |
| 2003 | +32.49% | $5.97 | $7.91 |
| 2002 | -22.50% | $7.70 | $5.97 |
| 2001 | +2.18% | $7.53 | $7.70 |
| 2000 | +30.99% | $5.75 | $7.53 |
| 1999 | +160.65% | $2.21 | $5.75 |
| 1998 | +20.71% | $1.83 | $2.21 |
| 1997 | +34.62% | $1.36 | $1.83 |
| 1996 | +29.19% | $1.05 | $1.36 |
| 1995 | +96.34% | $0.54 | $1.05 |
| 1994 | -6.82% | $0.57 | $0.54 |
| 1993 | -35.29% | $0.89 | $0.57 |
| 1992 | +33.33% | $0.67 | $0.89 |
| 1991 | +308.00% | $0.16 | $0.67 |
| 1990 | +127.27% | $0.07 | $0.16 |
Valuation
TECH currently trades at a trailing P/E ratio of 95.9, which is considered high relative to the broader market. The forward P/E of 23.4 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 3.9. The price-to-sales ratio is 6.5.
Dividends
Bio-Techne Corporation pays a dividend to shareholders with a current yield of 0.63%. This translates to $0.32 per share annually. The payout ratio of 60% indicates moderate dividend coverage.
Risk & Volatility
TECH has a beta of 1.48, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $46.01 to $72.16, and it currently trades near its 52-week low.
Analyst Ratings
Based on 12 analyst opinions, TECH has a consensus "buy" rating. The average price target of $75.25 suggests 48.0% upside from current levels.
Frequently Asked Questions
What does Bio-Techne Corporation do? ▼
Bio-Techne Corporation is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Minneapolis, United States.
What sector is TECH in? ▼
TECH operates in the Healthcare sector, specifically in the Biotechnology industry.
When did TECH go public? ▼
Bio-Techne Corporation went public in 1989, making it a 37-year-old public company as of 2026.
How much would $1,000 invested in TECH 5 years ago be worth today? ▼
A $1,000 investment in TECH five years ago would be worth approximately $571 today, representing a -42.9% return.
Does TECH pay dividends? ▼
Yes, Bio-Techne Corporation pays a dividend with a current yield of 0.63%, which is $0.32 per share annually.
What is TECH's market cap? ▼
Bio-Techne Corporation has a market capitalization of $8.0 billion, classifying it as a mid-cap company.
What is TECH's P/E ratio? ▼
TECH has a trailing P/E ratio of 95.9 and a forward P/E of 23.4, which measures how much investors are paying per dollar of earnings.
Is TECH a buy, hold, or sell? ▼
Based on 12 opinions, TECH has a consensus "buy" rating. The average price target is $75.25.
Last updated: 3/14/2026